PBGENE-HBV is Precision's wholly owned in vivo gene editing program under investigation in a global first-in-human clinical trial, which is designed to be a potentially curative treatment for chronic ...
Idvynso uniquely offers a two-drug, tenofovir-free, non-INSTI single-tablet regimen intended for switch in stable, suppressed ...
Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven ...
This approval marks an important new chapter in Merck’s long-standing commitment to research and discovery for people living ...
RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the independent presentation of new preclinical data at the 2026 American Association for ...
Explore 25 Historic Mysteries Scientists Are Still Unraveling, from vanished cities to lost treasures. Dive into ancient ...
Scientists have uncovered a surprising new picture of human origins that challenges the long-held idea of a single ancestral ...
Scientists have just discovered an entirely new way that DNA can be synthesized. The business of constructing DNA ...
Live Science on MSN
Unknown Asian 'ghost' population contributed to American ancestry, DNA study reveals
DNA reveals a previously unknown wave of people settled in South America 1,300 years ago and that Indigenous Americans carry remnants of a "ghost lineage." ...
In a new study, scientists analyzed one such strategy used by the bacterium Escherichia coli. One of the enzymes in the ...
Cyanobacteria—ancient microbes that oxygenated Earth and made complex life possible—are still revealing surprises billions of ...
The ability to precisely edit the genomes of bacteria has long been a goal of microbiologists. Such technology would enable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results